zacks.com · Sep 22, 2026
NASDAQ
15-minute delay
ALKERMES PLC COVERAGE
Latest Alkermes plc news
MARKET NEWS
Around the market
investors.com · Sep 21, 2026
How Alkermes Used Its Narcolepsy Playbook In ADHD — And Seemingly Won
Read article →
businesswire.com · Sep 21, 2026
Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Read article →
businesswire.com · Sep 16, 2026
Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors
Read article →
defenseworld.net · Sep 15, 2026
California State Teachers Retirement System Increases Holdings in Alkermes plc $ALKS
Read article →
seekingalpha.com · Sep 11, 2026
Alkermes: A Slow-Burning Buy Prospect On Orexin-Agonist Promise
Read article →KEY DATA POINTS
Financial snapshot
Revenue, profitability, balance-sheet, cash-flow, and valuation trends for Alkermes plc.
NASDAQ MARKET COMPARABLES
Similar companies
Ten established NASDAQ listings presented for broader market context.
NASDAQ reference
15-minute delay
AAPL
Apple
Large-cap technology
→
MSFT
Microsoft
Enterprise technology
→
NVDA
NVIDIA
AI & semiconductors
→
AMZN
Amazon
Commerce & cloud
→
GOOGL
Alphabet
Internet & AI
→
META
Meta Platforms
Digital platforms
→
AVGO
Broadcom
Semiconductors
→
TSLA
Tesla
Electric vehicles
→
COST
Costco
Consumer retail
→
NFLX
Netflix
Streaming media
→
TradingView renders the market-data table. Securities.io supplies only the editorial peer selection, comparison labels, and destination links.
COMPANY DETAILS
About Alkermes plc
Business description, sector, industry, leadership, headquarters, and workforce information.
SECURITIES.IO RESEARCH
Continue your research
NASDAQ market data on this page is labeled as 15 minutes delayed. Prices, charts, financials, company information, and the peer comparison are displayed by TradingView; Securities.io does not extract those values. This information is educational and is not investment advice.